Posted on

NJ Based Biotech Receives FDA Clearance of IND for its ‘Inflammation Regulator Protein,’ for the Treatment of ARDS

external content.duckduckgo 20

the staff of the Ridgewood blog

North Brunswick NJ, BioAegis Therapeutics, Inc., a clinical-stage company developing therapies for inflammatory diseases through a portfolio built around plasma gelsolin, a highly conserved and abundant endogenous human immune regulatory protein, announces that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for recombinant plasma gelsolin to proceed for the treatment of acute respiratory distress syndrome (ARDS).

Continue reading NJ Based Biotech Receives FDA Clearance of IND for its ‘Inflammation Regulator Protein,’ for the Treatment of ARDS

Posted on

FDA Shuts Down New Jersey Pet Food Manufacturer for , ‘grossly insanitary conditions’

277302725 5544238298937181 6066833291370445488 n

photo by ArtChick

the staff of the Ridgewood blog

Penns Grove NJ, The U.S. Food and Drug Administration (FDA) announced today that Bravo Packing, Inc., an animal food manufacturing company of Carney’s Point, New Jersey, has agreed to stop selling, manufacturing and distributing raw pet food and come into compliance with the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Continue reading FDA Shuts Down New Jersey Pet Food Manufacturer for , ‘grossly insanitary conditions’

Posted on

New York Man Admits Defrauding 70 Investors of More Than $3.5 Million through Securities Offering Scheme

external content.duckduckgo 58

the staff of the Ridgewood blog

Trenton NJ, a New York man today admitted perpetrating a scheme to defraud more than 70 investors through a long-running securities offering fraud that raised more than $4 million and caused investor losses of more than $3.5 million, Acting U.S. Attorney Rachael A. Honig announced.

Continue reading New York Man Admits Defrauding 70 Investors of More Than $3.5 Million through Securities Offering Scheme

Posted on

FDA Approves Aducanumab the first new treatment for Alzheimer’s disease in nearly 20 years

external content.duckduckgo 11

the staff of the Ridgewood blog

Ridgewood NJ, Aducanumab is the first new treatment for Alzheimer’s disease that has been approved for use in the US in nearly 20 years. It targets the underlying cause of the disease rather than its symptoms. While it is not a miracle drug, its approval will be a huge boost to dementia research. Alzheimer’s disease affects more than 30 million people around the world, most over the age of 65.

Continue reading FDA Approves Aducanumab the first new treatment for Alzheimer’s disease in nearly 20 years

Posted on

Johnson & Johnson Requests Emergency Use Authorization from FDA for One Dose COVID Vaccine

64310182 10156106202320951 9163112232647655424 n

 

the staff of the Ridgewood blog

New Brunswick NJ,  Johnson & Johnson (NYSE: JNJ) (the Company) today announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its investigational single-dose Janssen COVID-19 vaccine candidate. The Company’s EUA submission is based on topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose vaccine met all primary and key secondary endpoints. The Company expects to have product available to ship immediately following authorization.

Continue reading Johnson & Johnson Requests Emergency Use Authorization from FDA for One Dose COVID Vaccine

Posted on

What Ingredients are Really in the COVID Vaccines

138612631 1538890396315379 5598401216149344366 n

Clinical Contributors to this Story Juan C. Ravell, M.D. Hackensack Meridian Health

Hackensack NJ, The Pfizer-BioNTech and Moderna COVID-19 vaccines were given Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in mid-December 2020. Prior to authorization by the FDA, these vaccines underwent the same rigorous safety and effectiveness standards as all other vaccines. Quickly, vaccine distribution began, starting with health care professionals on the frontlines of patient care.

Continue reading What Ingredients are Really in the COVID Vaccines

Posted on

PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19 ACHIEVED 90% SUCCESS RATE

external content.duckduckgo 6

Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis

Analysis evaluated 94 confirmed cases of COVID-19 in trial participants

Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected

Submission for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) planned for soon after the required safety milestone is achieved, which is currently expected to occur in the third week of November

Clinical trial to continue through to final analysis at 164 confirmed cases in order to collect further data and characterize the vaccine candidate’s performance against other study endpoints

the staff of the Ridgewood blog

Continue reading PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19 ACHIEVED 90% SUCCESS RATE

Posted on

Governor Murphy Announces Acquisition of 15 Abbott ID NOW to Expand Access to COVID-19 Testing in New Jersey

IDNOW LEFT 960x430 1

the staff of the Ridgewood blog

 

Ridgewood NJ,  Governor Phil Murphy today announced the acquisition of 15 point-of-care ID NOW testing instruments from the federal government to expand access to COVID-19 testing in New Jersey. The portable, rapid testing machines will be dispersed to health care systems throughout the state, will be able to test for COVID-19 and process specimens in approximately 5-13 minutes.

Continue reading Governor Murphy Announces Acquisition of 15 Abbott ID NOW to Expand Access to COVID-19 Testing in New Jersey

Posted on

Assemblyman Kevin J. Rooney urges FDA to quickly test for new COVID-19 cases as state faces economic uncertainty

15325332 1168238156558382 9074927974489663494 o

US has conducted more COVID 19 tests in 8 days than South Korea did in 8 weeks. 

the staff of the Ridgewood blog

Ridgewood NJ,  Following Gov. Phil Murphy’s weekend executive order that mandated people stay home and shuttered all non-essential businesses, Assemblyman Kevin J. Rooney announced he was issuing a resolution to urge the U.S. Food and Drug Administration (FDA) to ramp up testing for COVID-19 so that people could return to work.

Continue reading Assemblyman Kevin J. Rooney urges FDA to quickly test for new COVID-19 cases as state faces economic uncertainty